Abdomen

Global Stomach Cancer Market and Competitive Landscape 2014-2023 - Pipeline, Epidemiology, Market Valuations, Product Sales, Market Forecast, Product Forecasts, and Market Shares

Retrieved on: 
Tuesday, November 6, 2018

The "Global Stomach Cancer Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Stomach Cancer Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering.
  • Global Stomach Cancer Market and Competitive Landscape - 2018, provides comprehensive insights into Stomach Cancer pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares.
  • This study accurately estimates and forecast Stomach Cancer market size and drug sales.
  • The research is classified into following sections - Stomach Cancer overview with definitions, symptoms, etiology, diagnosis, treatment options; Stomach Cancer pipeline insights covering late stage clinical trials pipeline; Stomach Cancer prevalence trends by countries; Stomach Cancer market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries.

Biostage to Host Conference Call to Discuss Third Quarter 2018 Financial Results and Operations

Retrieved on: 
Friday, November 2, 2018

Biostage management also announced that it will host a conference call with a live audio webcast that same day at 9:30 AM ET to review its operational progress and financial report.

Key Points: 
  • Biostage management also announced that it will host a conference call with a live audio webcast that same day at 9:30 AM ET to review its operational progress and financial report.
  • To participate in the call, please dial (877) 407-8293 (domestic) or (201) 689-8349 (international).
  • Based on its preclinical data, Biostage plans to address life-threatening conditions of the esophagus with the initial clinical applications of its technology.
  • Biostage's results may also be affected by factors of which Biostage is not currently aware.

Debbie's Dream Foundation to Host FREE Seattle Stomach Cancer Education Symposium and Webcast

Retrieved on: 
Monday, October 15, 2018

SEATTLE, Oct. 15, 2018 /PRNewswire/ --Debbie's Dream Foundation: Curing Stomach Cancer (DDF) will hold the Seattle Stomach Cancer Education Symposium and Webcast featuring a panel of leading oncologists and healthcare experts on Saturday, December 1, 2018.

Key Points: 
  • SEATTLE, Oct. 15, 2018 /PRNewswire/ --Debbie's Dream Foundation: Curing Stomach Cancer (DDF) will hold the Seattle Stomach Cancer Education Symposium and Webcast featuring a panel of leading oncologists and healthcare experts on Saturday, December 1, 2018.
  • The Seattle Stomach Cancer Education Symposium will provide an informative and engaging agenda that includes nationally recognized speakers along with healthcare professionals from Seattle's leading cancer treatment facilities.
  • Debbie's Dream Foundation: Curing Stomach Cancer (DDF) is a 501(c)(3) non-profit organization dedicated to raising awareness about stomach cancer, advancing funding for research, and providing education and support internationally to patients, families, and caregivers.
  • Debbie's Dream Foundation seeks as its ultimate goal to make the cure for stomach cancer a reality.

Scientists Grow Human Esophagus in Lab

Retrieved on: 
Thursday, September 20, 2018

CINCINNATI, Sept. 20, 2018 /PRNewswire/ -- Scientists working to bioengineer the entire human gastrointestinal system in a laboratory now report using pluripotent stem cells to grow human esophageal organoids.

Key Points: 
  • CINCINNATI, Sept. 20, 2018 /PRNewswire/ -- Scientists working to bioengineer the entire human gastrointestinal system in a laboratory now report using pluripotent stem cells to grow human esophageal organoids.
  • Cincinnati Children's scientists and their multi-institutional collaborators already have used PSCs to bioengineer human intestine, stomach, colon and liver.
  • "Disorders of the esophagus and trachea are prevalent enough in people that organoid models of human esophagus could be greatly beneficial," said Jim Wells, PhD , chief scientific officer at CuSTOM and study lead investigator.
  • The scientists used mice, frogs and human tissue cultures to identify other genes and molecular pathways regulated by Sox2 during esophagus formation.

Salix Announces U.S. Launch of PLENVU®, the First and Only 1-Liter PEG Bowel Cleansing Preparation for Colonoscopies

Retrieved on: 
Tuesday, September 11, 2018

PLENVU is now the lowest total volume requirement compared to any other prescription bowel prep.

Key Points: 
  • PLENVU is now the lowest total volume requirement compared to any other prescription bowel prep.
  • The American Cancer Society estimates colorectal cancer is expected to cause 50,630 deaths during 2018.
  • Both primary endpoints were met, achieving non-inferior overall bowel cleansing success and 'Excellent' and 'Good' cleansing of the ascending colon.
  • In clinical studies with PLENVU, the most common side effects in patients taking PLENVU were nausea, vomiting, dehydration, and abdominal pain/discomfort.

InventHelp Inventor Develops Lint Trap for Washing Machines (CCP-1374)

Retrieved on: 
Monday, August 27, 2018

PITTSBURGH, Aug. 27, 2018 /PRNewswire/ --"Whenever you wash clothes, lint and debris comes out of the washing machine discharge hose," said an inventor from Beach Park, Ill. "Over time, the lint sticks and accumulates, which causes clogs that require costly maintenance.

Key Points: 
  • PITTSBURGH, Aug. 27, 2018 /PRNewswire/ --"Whenever you wash clothes, lint and debris comes out of the washing machine discharge hose," said an inventor from Beach Park, Ill. "Over time, the lint sticks and accumulates, which causes clogs that require costly maintenance.
  • He created a prototype for the patent pending LINT TRAP to filter undesired waste (lint) from the washing machine so that it does not enter the pipe drainage system.
  • The unit prevents lint from clogging pipes and creating a costly problem.
  • 17-CCP-1374, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext.

InventHelp Inventor Develops Enhanced Abdominal and Cardiovascular Exerciser (SKC-429)

Retrieved on: 
Monday, August 13, 2018

PITTSBURGH, Aug. 13, 2018 /PRNewswire/ --An inventor from Dickenson, Texas, wanted a more comfortable option than lying on a floor to exercise.

Key Points: 
  • PITTSBURGH, Aug. 13, 2018 /PRNewswire/ --An inventor from Dickenson, Texas, wanted a more comfortable option than lying on a floor to exercise.
  • His creative thinking led him to design a machine with both cardiovascular and abdominal benefits that does not place any strain on the back.
  • As such, it provides a low-impact cardiovascular workout as well as helping to strengthen and tone muscles in the abdomen, core and legs.
  • "I found lying on my back on the floor to do abdominal exercises very uncomfortable," he said.

Biostage to Host Conference Call to Discuss Second Quarter 2018 Financial Results and Operations

Retrieved on: 
Thursday, August 9, 2018

Biostage management also announced that it will host a conference call with a live audio webcast that same day at 9:00 AM ET to review its operational progress and financial report.

Key Points: 
  • Biostage management also announced that it will host a conference call with a live audio webcast that same day at 9:00 AM ET to review its operational progress and financial report.
  • To participate in the call, please dial (877) 407-8293 (domestic) or (201) 689-8349 (international).
  • Based on its preclinical data, Biostage has selected life-threatening conditions of the esophagus as the initial clinical application of its technology.
  • The Company's results may also be affected by factors of which the Company is not currently aware.

Global Gastrointestinal Partnering 2012-2018: Deal trends, players and financials

Retrieved on: 
Wednesday, August 8, 2018

NEW YORK, August 8, 2018 /PRNewswire/ -- Global Gastrointestinal Partnering 2012 to 2018 provides the full collection of Gastrointestinal disease deals signed between the world's pharmaceutical and biotechnology companies since 2012.

Key Points: 
  • NEW YORK, August 8, 2018 /PRNewswire/ -- Global Gastrointestinal Partnering 2012 to 2018 provides the full collection of Gastrointestinal disease deals signed between the world's pharmaceutical and biotechnology companies since 2012.
  • The report takes readers through the comprehensive Gastrointestinal disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Gastrointestinal deals.
  • Chapter 6 provides a comprehensive directory of all Gastrointestinal partnering deals by specific Gastrointestinal target announced since 2012.
  • In Global Gastrointestinal Partnering 2012 to 2018, available deals and contracts are listed by:

New study shows that peptic ulcers caused by H. pylori should be taken seriously and treated promptly

Retrieved on: 
Monday, August 6, 2018

Helicobacter pylori, often called H. pylori, is a type of bacteria that can enter the body and live in the digestive tract.

Key Points: 
  • Helicobacter pylori, often called H. pylori, is a type of bacteria that can enter the body and live in the digestive tract.
  • Over time, it can cause ulcers in the stomach lining or small intestine that can lead to a range of diseases from peptic ulcer disease to cancer.
  • Most peptic (digestive tract) ulcers are thought to be caused by H. pylori infection.
  • The study looked at more than 29,000 patients receiving H. pylori eradication therapy following a peptic ulcer disease diagnosis from 2005 to 2013.